PlainPharmaWatch

CMS Open Payments · Program Year 2024

Axsome Therapeutics, Inc.

Axsome Therapeutics, Inc. reported $23,555,020.52 in payments to 79,802 physicians and teaching hospitals across 80,352 transactions.

See the rankings → How this is sourced
$23.6M
Total payments
80,352
Transactions
79,802
Recipients
+$3.5M
General Payments vs PY2023

Axsome Therapeutics, Inc. reported $23,555,020.52 in payments to 79,802 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #84 of 1,925 reporting manufacturers (0.2% of all US industry payments), averaging $295.17 per recipient across 6 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Axsome Therapeutics, Inc. pairs top-5% payment volume with an unusually diversified payment pattern across a wide recipient base.

#84
of 1,925 companies
0.2%
of all US industry payments
0.0%
paid to its single top recipient
6
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

Axsome Therapeutics, Inc.'s CMS-reported General Payments increased by $3.5M (+39.8%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: AXSOME THERAPEUTICS, INC.PY2023: AXSOME THERAPEUTICS, INC.PY2024: Axsome Therapeutics, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$8.7MPY2024$12.2M
PY2023
$8,747,928.20
PY2024
$12,229,272.83

How Axsome Therapeutics, Inc. ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Axsome Therapeutics, Inc.'s total vs. every reporting company

CMS Open Payments, Program Year 2024

$23,555,021 Top 4% higher than 96% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). Below this entry. $752,621–$2,337,813: 263 reporting companies (14%). Below this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). Below this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Below this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). This entry sits in this band. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Axsome Therapeutics, Inc.

Averaging $293.15 per transaction and $295.17 per recipient, Axsome Therapeutics, Inc.'s Program Year 2024 total comes to $23,555,020.52 across 80,352 transactions and 79,802 physicians and teaching hospitals. In the CMS Open Payments database that is good for rank #84 of 1,925 companies, representing 0.2% of all industry payments reported nationwide for the year.

The 6-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Consulting Fee" at $8.7M, accounting for 36.7% of the company's reported total and 3,538 transactions.

General Payment Breakdown by Type

"Consulting Fee" leads Axsome Therapeutics, Inc.'s 6-category general-payment breakdown at $8.7M, 36.7% of the reported total.

How Axsome Therapeutics, Inc. divides its payments

How the reported total splits across payment categories

1. Consulting Fee$8.7M2. Food and Beverage$2.4M3. Travel and Lodging$945.4K4. Compensation for Faculty …$239.3K5. Education$4.2K6. Space Rental or Facility …$3.5K
Payment Type Amount Transactions
Consulting Fee $8.7M 3,538
Food and Beverage $2.4M 72,011
Travel and Lodging $945.4K 3,718
Compensation for Faculty or Speaker (Medical Education) $239.3K 116
Education $4.2K 418
Space Rental or Facility Fees $3.5K 1

Recipient Concentration in General Payments

The five largest recipient relationships account for $889,273.08 (7.3%) of $12,229,272.83 in this company's General Payments records across 27,135 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Axsome Therapeutics, Inc.

The five named recipients with the highest reported General Payments from this company

Leon Rosenberg$249.4KGregory Mattingley$175.3KScott Wiener$162.4KCraig Chepke$152.3KAndrew Cutler$149.9K
  1. 1

    Leon Rosenberg

    $249,399.95 across 22 reported transactions

  2. 2

    Gregory Mattingley

    $175,349.15 across 164 reported transactions

  3. 3

    Scott Wiener

    $162,397.43 across 234 reported transactions

  4. 4

    Craig Chepke

    $152,275.59 across 118 reported transactions

  5. 5

    Andrew Cutler

    $149,850.96 across 133 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $293.15. Average per recipient: $295.17.

Total Amount

$23,555,020.52

Avg per Transaction

$293.15

Avg per Recipient

$295.17

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Axsome Therapeutics, Inc. Share

0.2%

#84 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Axsome Therapeutics, Inc.

Alcon Research LLC

$23.7M 795 recipients

Grace Medical, Inc.

$24.1M 51 recipients

Bausch Health US, LLC

$22.5M 9,197 recipients

Regeneron Healthcare Solutions, Inc.

$24.7M 169,362 recipients

Alphatec Spine, Inc

$22.3M 6,836 recipients

Deciphera Pharmaceuticals Inc.

$21.9M 3,335 recipients

Frequently Asked Questions

How much did Axsome Therapeutics, Inc. pay to physicians and hospitals in 2024? ▾
In Program Year 2024, CMS Open Payments recorded $23,555,020.52 from Axsome Therapeutics, Inc. to physicians and hospitals across 80,352 transactions - 0.2% of all industry payments reported that year.
How many physicians received payments from Axsome Therapeutics, Inc.? ▾
Averaging $295.17 per recipient, Axsome Therapeutics, Inc.'s 2024 payments reached 79,802 physicians and teaching hospitals.
What types of payments did Axsome Therapeutics, Inc. make? ▾
General payments from Axsome Therapeutics, Inc. span 6 distinct categories, covering things like consulting, meals, and travel. The largest general-payment category was "Consulting Fee" at $8.7M, representing 36.7% of the company's reported total.
How does Axsome Therapeutics, Inc. rank among pharmaceutical companies? ▾
Out of 1,925 companies in the CMS Open Payments database for 2024, Axsome Therapeutics, Inc. ranks #84 by total payment amount.
What is the average payment size from Axsome Therapeutics, Inc.? ▾
Axsome Therapeutics, Inc.'s 80,352 transactions to 79,802 recipients in 2024 averaged $293.15 per transaction.
Where does the payment data for Axsome Therapeutics, Inc. come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Axsome Therapeutics, Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.